title: [Reactivation of hepatitis B after cessation of Rituximab monotherapy].
authors.forename: Stéphane
authors.initials: S
authors.lastname: Nancey
authors.forename: Driffa
authors.initials: D
authors.lastname: Moussata
authors.forename: Arnaud
authors.initials: A
authors.lastname: Tantin
authors.forename: Ahmad
authors.initials: A
authors.lastname: Wassouf
authors.forename: François-Xavier
authors.initials: FX
authors.lastname: Gadroy
authors.forename: Thierry
authors.initials: T
authors.lastname: Vial
authors.forename: Sylvette
authors.initials: S
authors.lastname: Claudel
authors.forename: Jean-Christophe
authors.initials: JC
authors.lastname: Saurin
authors.forename: Bernard
authors.initials: B
authors.lastname: Flourie
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D006509:Hepatitis B / Q000209:etiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab